Navigation Links
Testicular cancer linked to high cholesterol

High levels of cholesterol in the blood can increase the risk of having testicular cancer in men.// The research which came in the recent issue of British Journal of Cancer says that the increase in blood cholesterol level can increase the risk of testicular cancer by almost as much as 4.5 % than for people with a healthy level of cholesterol.

The Swedish researchers from Karolinska University Hospital had looked into the data of 44,864 men taken and followed up for a period of 25 years. Of the entire data there were 21 cases of testicular cancer that were reported in the time span under scrutiny. There was a positive correlation between the incidence of testicular cancer and high levels of blood cholesterol. The risks of testicular cancer associated with middle level of serum cholesterol category is about 1.3 times to a normal healthy person with low levels of cholesterol, while the risk can increase to 4.5 times for person falling in the highest level of serum cholesterol category..

For men in the age group of 15 to 44, testicular cancer is one of the common forms of cancer, whose incidence had increased in the recent times due to intake of more fatty foods in the diets amongst most other things..

Researchers feel that this may be first instance where testicular cancer had been linked to serum cholesterol levels..

Reference: British Journal of Cancer, May 2005
'"/>




Page: 1

Related medicine news :

1. Fertility After Testicular Cancer Questioned
2. Life After Testicular Cancer
3. New Screening Method Found To Detect Testicular Cancer In Its Initial Stages
4. Carboplatin Drug Is More Effective Than Radiation Therapy For Testicular Cancer
5. Treating Testicular Cancer With A Single Dose Of Chemotherapy
6. Testicular cancer identified
7. New Treatment Option For Testicular Cancer
8. Testicular Cancer Patients Have Improved Reproductive Outcomes After Treatment
9. Decline in Paternity Rates Following Treatment for Testicular Cancer
10. Human Testicular Cells Would Help In Stem Cell Research
11. An Eye on Increase in Testicular Cancer
Post Your Comments:
(Date:8/28/2008)...f the Maryland Medicaid contract, HARRISBURG, Pa....l,management firm, appointed Lenaye Lawyer, MD, FA...er will oversee all clinical aspects of Medicaid,o...Maryland Harrisburg,office., "Dr. Lawyer has prac...,Alice Stollenwerk Petrulis, MD, FACP, Chief Medic...
(Date:8/28/2008)...heast region with more hires,planned throughout th...g. 28 /PRNewswire-USNewswire/ -- The Pennsylvania,...y Liaison for the,Northeast region to help healthc...ient Safety Reporting System (PA-PSRS) improve pat...r in focus groups with Pennsylvania Patient Safety...
(Date:8/28/2008)...t patients and doctors say drug is hard to manage ...- Only 40 percent of patients with atrial fibrilla...er a stroke were taking the anti-clotting drug war...warfarin, 75 percent weren,t getting the dose need...nt were taking medications that were less effectiv...
(Date:8/28/2008)...logy company serves growing professional and consu...alo Alto, CA (PRWEB) August 28, 2008 -- Trident Ca...y announced that together with Mustang Ventures, i...s A round of financing for Profex.Inc. Trident Cap... million in the round. Profex, a leading Dermatolo...
Breaking Medicine News(10 mins):Health News:Lenaye Lawyer, MD, FACOG, Named KePRO Medical Director 2Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 2Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 3Health News:Most Patients With Irregular Heartbeat Take Inadequate Blood Thinner Dose 2Health News:Most Patients With Irregular Heartbeat Take Inadequate Blood Thinner Dose 3Health News:Trident Capital and Mustang Ventures Lead Series A Investment in Profex, Inc. 2Health News:Trident Capital and Mustang Ventures Lead Series A Investment in Profex, Inc. 3
Plump Infants Getting Obese Later In Life In More Cases
...ound that there is no link whatsoever between brea...atins or lipid lowering drugs //to control the sam...October 24 issue of Archives of Internal Medicine,... article says that although some evidence has been...
... likely to invoke the compulsory licensing (CL) pr...tic drug //firms to produce and stockpile Swiss dr...combating the global threat against the most dread...ers the government to issue CL without receipt of ...
...ial lung disease (ILD) comprises a large, heteroge...rized by diffuse infiltrates, restrictive lung dis...mortality and morbidity. ILD presents enormous dia...ial diagnosis includes more than 100 conditions in...
Other Medicine News:Health News:A New Diagnostic Approach To Pediatric Interstitial Lung Disease 2
(Date:8/28/2008)... to collaborate on studies of immunosuppression ...diated immunity, COLUMBIA, Md., Aug. 28 /PRNewswi...n distributor, Sun Woo Biotech, is delighted to be...enter trial of the ImmuKnow assay,for cell-mediate...tutions,in the Republic of Korea," stated Brad Ste...
(Date:8/28/2008)... /- Intercell AG (VSE: ICLL) today,an...s initiated a Phase II,clinical trial of V710, an ...hylococcus aureus (S. aureus) infections. This ran...s to evaluate the safety and immunogenicity of,the...ey disease on,hemodialysis. This trial start follo...
(Date:8/27/2008)...in Parts of Bucks, Delaware, Montgomery,Philadelp...e-USNewswire/ -- After encouraging,results followi...tment of,Environmental Protection will continue it...st the mosquito-borne West Nile virus., Targeted ....m. and,midnight in portions of Bucks, Delaware, M...
(Date:8/27/2008)..., melphalan and prednisone arm demonstrated a, si... complete response -, CAMBRIDGE, Mass., Aug. 27 /...pany today announced the publication of results fr... trial in this week,s edition of the,New England J...nt survival,benefit and a 30 percent complete remi...
Breaking Medicine Technology:Cylex Announces Plan for Multi-Center Trial of ImmuKnow(R) Assay in South Korea 2Cylex Announces Plan for Multi-Center Trial of ImmuKnow(R) Assay in South Korea 3Intercell Announces Initiation of Further Phase II Clinical Trial of V710 an Investigational Vaccine to Prevent S. aureus Infection 2Intercell Announces Initiation of Further Phase II Clinical Trial of V710 an Investigational Vaccine to Prevent S. aureus Infection 3DEP to Complete Aerial Mosquito Treatments to Stem West Nile Virus in Southeastern Counties 2DEP to Complete Aerial Mosquito Treatments to Stem West Nile Virus in Southeastern Counties 3New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 2New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 3New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 4New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 5New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 6State of Arkansas Department of Human Services Division of Medical Services Selects U S Care Management for High Risk Obstetrics Health Management P 6752 1State of Arkansas Department of Human Services Division of Medical Services Selects U S Care Management for High Risk Obstetrics Health Management P 6752 2State of Arkansas Department of Human Services Division of Medical Services Selects U S Care Management for High Risk Obstetrics Health Management P 6752 3State of Arkansas Department of Human Services Division of Medical Services Selects U S Care Management for High Risk Obstetrics Health Management P 6752 4CardioMag Announces Results of 2006 Annual Shareholders Meeting and Board Meeting 1885 1CardioMag Announces Results of 2006 Annual Shareholders Meeting and Board Meeting 1885 2Amicus Therapeutics to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference 1881 1Amicus Therapeutics to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference 1881 2Amicus Therapeutics to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference 1881 3Penn researchers find monkeys able to fend off AIDS like symptoms with enhanced HIV vaccine 1293 1Penn researchers find monkeys able to fend off AIDS like symptoms with enhanced HIV vaccine 1293 2
...ncer Conference, NORTH HOLLYWOOD, Calif., and CHIC...al Myeloma Foundation (IMF)-supporting research,an...eloma patients,families, researchers and physicia...e 3 multi- national clinical trial shows the,combi...obability of,survival by 41%. The follow-up study ...
...ity Support Development of Panzem(R),NCD as a Comb...ILLE, Md., June 05, 2007 /PRNewswire-FirstCall/ --...company developing,therapeutics for the treatment ... presentation of results of a single-agent Phase 2...lioblastoma,multiforme (GBM). The data were presen...
Other Medicine Technology:Study Shows Velcade Plus Doxil Improves Survival in Previously,Treated Patients With Multiple Myeloma 2Phase 2 Results for EntreMed's Panzem NCD Brain Cancer Study,Presented at ASCO 2Phase 2 Results for EntreMed's Panzem NCD Brain Cancer Study,Presented at ASCO 3Phase 2 Results for EntreMed's Panzem NCD Brain Cancer Study,Presented at ASCO 4
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
Medicine Products: